About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 702 record(s)
Req # A-2021-001677
Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report Number: 000959916.Organization: Health Canada
March 2022
Req # A-2021-001678
Adverse Drug Reaction (ADRs) for GLYCERYL TRINITRATE. Report Number: 000960606.Organization: Health Canada
March 2022
Req # A-2021-001679
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report Number: E2B_04402032.Organization: Health Canada
March 2022
Req # A-2021-001686
Adverse Drug Reaction (ADRs) for ZOPICLONE. Report Numbers: 000961941, E2B_04558723, E2B_04524456, E2B_04501464.Organization: Health Canada
March 2022
Req # A-2021-001696
Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE. Report Numbers: E2B_04548621, E2B_04170327.Organization: Health Canada
March 2022
Req # A-2021-001697
Adverse Drug Reactions (ADRs) for GLYCERYL TRINITRATE. Report Numbers: E2B_04123396, E2B_04535839.Organization: Health Canada
March 2022
Req # A-2021-001698
Adverse Drug Reaction (ADR) for ACEBUTOLOL HYDROCHLORIDE. Report Number: E2B_04206627.Organization: Health Canada
March 2022
Req # A-2021-001700
Adverse Drug Reaction (ADR) for BISACODYL. Report Number: 000958454.Organization: Health Canada
March 2022
Req # A-2021-001703
Adverse Drug Reactions (ADRs) for MMR II. Report Numbers: E2B_01928930, E2B_02063166, E2B_02073840, 000718882, E2B_02558683, E2B_02327669, E2B_02345618, E2B_01951540, E2B_01951549, 000724604.Organization: Health Canada
March 2022
Req # A-2021-001713
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075658-600.Organization: Health Canada
March 2022